CL2009000117A1 -
Compounds derived from carboxamide or azabicyclic carboxathioamide, trpv1 modulators; pharmaceutical composition that contains them; process of preparation of compounds and intermediates; and use in the treatment of pain, inflammation, metabolic disorders, among others.
- Google Patents
Compounds derived from carboxamide or azabicyclic carboxathioamide, trpv1 modulators; pharmaceutical composition that contains them; process of preparation of compounds and intermediates; and use in the treatment of pain, inflammation, metabolic disorders, among others.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=65681823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2009000117(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi AventisfiledCriticalSanofi Aventis
Priority to CL2009000117ApriorityCriticalpatent/CL2009000117A1/en
Publication of CL2009000117A1publicationCriticalpatent/CL2009000117A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Compuestos derivados de biciclos de carboxamida aza-bicíclicas, moduladores de los receptores trpv1; procedimiento de preparación; compuestos intermediarios; composición farmacéutica; y su uso para prevenir o tratar el dolor, inflamación, trastornos metabólicos, urológicos, gastrointestinales, herpes, depresión, entre otros.Compounds derived from aza-bicyclic carboxamide bicycles, modulators of trpv1 receptors; preparation procedure; intermediary compounds; pharmaceutical composition; and its use to prevent or treat pain, inflammation, metabolic, urological, gastrointestinal disorders, herpes, depression, among others.
CL2009000117A2009-01-212009-01-21
Compounds derived from carboxamide or azabicyclic carboxathioamide, trpv1 modulators; pharmaceutical composition that contains them; process of preparation of compounds and intermediates; and use in the treatment of pain, inflammation, metabolic disorders, among others.
CL2009000117A1
(en)
Compounds derived from carboxamide or azabicyclic carboxathioamide, trpv1 modulators; pharmaceutical composition that contains them; process of preparation of compounds and intermediates; and use in the treatment of pain, inflammation, metabolic disorders, among others.
Compounds derived from carboxamide or azabicyclic carboxathioamide, trpv1 modulators; pharmaceutical composition that contains them; process of preparation of compounds and intermediates; and use in the treatment of pain, inflammation, metabolic disorders, among others.
Compounds derived from carboxamide or azabicyclic carboxathioamide, trpv1 modulators; pharmaceutical composition that contains them; process of preparation of compounds and intermediates; and use in the treatment of pain, inflammation, metabolic disorders, among others.
Compounds derived from n-aza-bicyclic carboxamides; intermediate compounds; preparation procedure; pharmaceutical composition; and their use as antagonists or agonists of the trpv1-like receptor to treat pain, inflammation, metabolic, urological, gynecological, gastrointestinal, respiratory disorders.
Compounds derived from benzo (1,4) dioxin-2-ylmethyl-sulfamide; pharmaceutical compositions containing them; process to prepare them and use in the treatment of anxiety, epilepsy, pain, substance abuse, related disorders, among others.
Compounds derived from 5-fluoro-1h-pyrazolopyridine; preparation procedure for these; framaceutic composition that understands them; and its use in the treatment of cardiovascular, sexual and metabolic diseases.
Compounds derived from triazolopyridine, 11-beta-hydroxysteroid dehydrogenase type I inhibitors; pharmaceutical composition comprising them; and its use in the treatment and / or prevention of diabetes, dyslipidemia, obesity, among others.
Compounds derived from substituted pyrazolo-pyrimidines; pharmaceutical composition and combination that comprise them; and its use as inhibitors of pde9 for the treatment, relief and / or prevention of cognitive impairments related to perception, Alzheimer's, sleep disorders, bipolar disorder, diabetes mellitus.
Compounds derived from carboxamide and urea comprising aromatic substituted pyrazole, vanilloid receptor binders; pharmaceutical composition that includes them; and its use in the treatment and / or prophylaxis of pain, migraine, parkinson's disease, gastrointestinal disorders, osteoporosis, among other diseases.
Heterocyclic derived compounds, cb2 modulators; pharmaceutical composition comprising them; and use in the treatment of rheumatic, autoimmune, inflammatory diseases, pain, among others.
Compounds derived from substituted 1,4-benzodiazepines, dipeptidylpeptidase inhibitors iv (dpp-iv); pharmaceutical composition; preparation procedure; and its use in the treatment of diseases such as type 2 diabetes, cataracts, glaucoma, benign prostatic hypertrophy, cancer, among others; intermediate compounds.
Compounds derived from substituted benzofuran, modulators of the igf1 signaling agent or activator of protein kinase b; pharmaceutical composition that includes them; Useful in the treatment of diseases of the CNS, such as Alzheimer's, among others.
Compounds derived from (4-phenylimidazol-2-yl) ethylamine, such as sodium channel modulators; pharmaceutical composition that includes them; and its use in the treatment of pain.
Compounds derived from 1,3-disubstituted-4-phenyl-1h-pyridin-2-one, allosteric modulators of the glutamatergic receptor mglur2; Pharmaceutical composition and use of the compounds in the treatment of neurological and psychiatric conditions mediated by mglur2.
Compounds derived from n-heterocyclyl-2-sulfonyl acetamide, cb2 receptor modulators, useful for the treatment of pain, pulmonary, rheumatic, autoimmune disease, among others.
Compounds derived from substituted benzoylamino-indan-2-carboxylic acids, inhibitors of the cxcr5 receptor; pharmaceutical composition; and its use in the treatment of inflammatory physiological effects, such as rheumatoid arthritis and asthma.
Substituted benzamide derivative compounds, as modulators of taar; preparation procedure; pharmaceutical composition; and its use in the treatment of depression, anxiety disorders, bipolar disorder, schizophrenia, epilepsy, migraine, Alzheimer's disease, metabolic disorders, among others.
Aromatic fluoroglycoside derivatives, pharmaceutical composition containing these compounds, procedure to prepare it and its use in the treatment of type 1 and type 2 diabetes.
Compounds derived from piperidinyl substituted lactams, modulators of gpr119; Preparation process; pharmaceutical composition that includes them; treatment method; and use of the compound to treat diseases such as type 2 diabetes, metabolic syndrome, dyslipidemia, hypertension and schizophrenia, among others.
Compounds derived from amides, modulators of the taar1 receptor; obtaining process; pharmaceutical composition; and use in the treatment of diseases such as depression, anxiety, stress, among others.